TRUP logo

Trupanion, Inc. Stock Price

NasdaqGM:TRUP Community·US$965.3m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author

TRUP Share Price Performance

US$21.46
-26.69 (-55.43%)
US$52.00
Fair Value
US$21.46
-26.69 (-55.43%)
58.7% undervalued intrinsic discount
US$52.00
Fair Value
Price US$21.46
AnalystHighTarget US$52.00
AnalystConsensusTarget US$39.75
AnalystLowTarget US$31.00

TRUP Community Narratives

·
Fair Value US$52 58.7% undervalued intrinsic discount

Rising Pet Humanization And Digital Adoption Will Reshape Markets

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$39.75 46.0% undervalued intrinsic discount

Increasing Pet Ownership And Data Analytics Will Expand Market

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
·
Fair Value US$31 30.8% undervalued intrinsic discount

Intensifying Competition Will Erode Pet Insurance Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$52
58.7% undervalued intrinsic discount
Revenue
9.5% p.a.
Profit Margin
2.62%
Future PE
57.59x
Price in 2029
US$63.58
US$31
30.8% undervalued intrinsic discount
Revenue
9.16% p.a.
Profit Margin
0.94%
Future PE
97.52x
Price in 2029
US$37.59

Trending Discussion

Updated Narratives

TRUP logo

TRUP: Rebased P/E And Margin Assumptions Will Support Long Term Upside

Fair Value: US$39.75 46.0% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
TRUP logo

TRUP: Recalibrated Expectations And Higher Future P/E Will Support Long-Term Repricing

Fair Value: US$52 58.7% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
TRUP logo

TRUP: Clustered Price Cuts And P/E Reset Will Shape Future Returns

Fair Value: US$31 30.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Adequate balance sheet with questionable track record.

2 Risks
2 Rewards

Trupanion, Inc. Key Details

US$1.5b

Revenue

US$1.2b

Cost of Revenue

US$330.9m

Gross Profit

US$305.1m

Other Expenses

US$25.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.59
22.34%
1.74%
27.7%
View Full Analysis

About TRUP

Founded
2006
Employees
1121
CEO
Margaret Rosemary Tooth
WebsiteView website
www.trupanion.com

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.

Recent TRUP News & Updates

Narrative Update Jun 01

TRUP: Rebased P/E And Margin Assumptions Will Support Long Term Upside

Trupanion's analyst price target is updated from $46.25 to $39.75 as analysts factor in refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations, reflected in recent Street research cuts from BofA, Cantor Fitzgerald, and Stifel. Analyst Commentary Recent Street research indicates that the lower price targets are tied to refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations.
Seeking Alpha May 26

Trupanion: The Stock Has De-Rated, But The Problems Haven't

Summary Trupanion maintains respectable revenue growth and record subscription margins, but growth is driven by price increases, not pet enrollment. Pet enrollment continues at a sluggish 5% annual rate, while customer acquisition costs and veterinary inflation outpace revenue growth, pressuring unit economics. Management's digital-first product launch targets younger demographics but carries high execution risk and is unlikely to materially impact 2026 results. Despite a strong balance sheet and lower valuation, TRUP's core growth and competitive challenges justify maintaining a sell rating. Read the full article on Seeking Alpha

Recent updates

No updates